18-50663980-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002747.4(MAPK4):āc.22A>Gā(p.Ile8Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,612,704 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002747.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAPK4 | ENST00000400384.7 | c.22A>G | p.Ile8Val | missense_variant | 2/6 | 1 | NM_002747.4 | ENSP00000383234.1 | ||
MAPK4 | ENST00000588540.1 | c.22A>G | p.Ile8Val | missense_variant | 2/3 | 1 | ENSP00000465661.1 | |||
MAPK4 | ENST00000592595.5 | c.22A>G | p.Ile8Val | missense_variant | 2/4 | 1 | ENSP00000466233.1 | |||
MAPK4 | ENST00000540640.3 | c.-87-51099A>G | intron_variant | 2 | ENSP00000439231.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 248404Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134724
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1460646Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 726488
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | The c.22A>G (p.I8V) alteration is located in exon 2 (coding exon 1) of the MAPK4 gene. This alteration results from a A to G substitution at nucleotide position 22, causing the isoleucine (I) at amino acid position 8 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at